Palonosetron

lonosetron HCl is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting.A serotonin 5-HT3 receptor antagonist.

lonosetron HCl is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting.A serotonin 5-HT3 receptor antagonist.

Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.A novel PI3K/Akt/mTOR inhibitor with a GI50 of &lt:35 μM in the NCI-60 cell lines

Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.A novel PI3K/Akt/mTOR inhibitor with a GI50 of &lt:35 μM in the NCI-60 cell lines

Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.A novel PI3K/Akt/mTOR inhibitor with a GI50 of &lt:35 μM in the NCI-60 cell lines

Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.A novel PI3K/Akt/mTOR inhibitor with a GI50 of &lt:35 μM in the NCI-60 cell lines

Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.A novel PI3K/Akt/mTOR inhibitor with a GI50 of &lt:35 μM in the NCI-60 cell lines

Poloxin.

Poloxin.

Poloxin.

Gastrin Ⅰ, human.

Gastrin Ⅰ, human.